Systemic aluminum toxicity: Effects on bone, hematopoietic tissue, and kidney

Journal of Toxicology and Environmental Health - Part A

Volumn 48, Issue 6, 1996, Pages 649-665

  Jeffery, E H ^a   Abreo, K ^b   Burgess, E ^c   Cannata, J ^d   Greger, J L ^e  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF OVIEDO   (Spain)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; DEFEROXAMINE; PARATHYROID HORMONE;

ANEMIA; BONE DISEASE; BONE REMODELING; CLINICAL FEATURE; CONFERENCE PAPER; HEMATOPOIETIC TISSUE; HUMAN; IRON METABOLISM; KIDNEY FAILURE; MITOGENESIS; NEPHROTOXICITY; OSSIFICATION; OSTEOMALACIA; PRIORITY JOURNAL;

ALUMINUM; ANIMALS; BONE AND BONES; CELL MEMBRANE; CELLS; GTP-BINDING PROTEINS; HEMATOPOIETIC SYSTEM; HUMANS; KIDNEY; MINERALS; OXIDATIVE STRESS; RESEARCH DESIGN;

ANIMALIA;

EID: 0029797567     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Abdulla, M., Sevensson, S., and Haeger-Aronson, B. 1979. Antagonistic effects of zinc and aluminum on lead-inhibition of delta aminolevulinic acid dehydratase. Arch. Environ. Health 34:464-479.
2. Abreo, K., Brown, S. T., and Sella, M. 1989. Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate. Am. J. Kidney Dis. 13:465-468.
3. Abreo, K., Glass, J., and Sella, M. 1990. Aluminum inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells. Kidney Int. 37:677-681.
4. Abreo, K., Glass, J., Jain, S., and Sella, M. 1994. Aluminum alters the compartmentalization of iron in Friend erythroleukemia cells. Kidney Int. 45:636-641.
5. Alfrey, A. C. 1980. Metabolism and toxicity of aluminum in renal failure. Am. J. Clin. Nutr. 33:1509-1516.
6. Andress, D., Felsenfeld, A. J., Voigts, A., and Llach, F. 1983. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int. 24:364-370.
7. Bertholf, R. L., Herman, M. M., Savory, J., Carpenter, R. M., Sturgill, C. G., Katsetos, C. D., Vandenberg, S. R., and Wills, M. R. 1989. A long term intravenous model of aluminum maltol toxicity in rabbits. Toxicol. Appl. Pharmacol. 98:58-74.
8. Bittar, E. E., and Huang, Y. P. 1990. The behavior of ouabain-insensitive sodium efflux in single barnacle muscle fibres toward the microinjection of aluminum. Toxicol. Appl. Pharmacol. 106:71-79.
9. Buchet, J. P., Lauwerys, R., Hassoun, A., Dratwa, M., Wens, R., Collart, F., and Tielemans, C. 1987. Effect of aluminum on porphyrin metabolism in hemodialysis patients. Nephron 46:360-363.
10. Burnatowska-Hledin, M. A., Klein, A. M., and Mayor, G. H. 1985a. Effect of aluminum on renal phosphate handling in the rat. Am. J. Physiol. 248:F64-F69.
11. Burnatowska-Hledin, M. A., Mayor, G. H., and Lau, K. 1985b. Renal handling in the rat: Clearance and micropuncture studies. Am. J. Physiol. 249:F192-F197.
12. Buys, S. S., and Kushner, J. P. 1989. Hematologic effects of aluminum toxicity. In Aluminum and health: A critical review, ed. H. Gitelman, pp. 235-256. New York: Marcel Dekker.
13. Cacini, W., and Yokel, R. A. 1988. Accumulation of aluminum in rabbit renal cortex. Res. Commun. Chem. Pathol. Pharmacol. 59:93-105.
14. Cannata, J. B., and Diaz Lopez, J. B. 1991. Insights into the complex aluminum and iron relationship. Nephrol. Dial. Transplant 6:605-607.
15. Cannata, J. B., Ruiz, M. P., Algeria, P., Cuesta, M. V., Herrera, J., and Peral, V. 1983. Influence of aluminum hydroxide intake on hemoglobin concentration and blood transfusion requirements in hemodialysis patients. Proc. Eur. Dial. Transplant Assoc. 20:719-722.
16. Cannata, J. B., Fernandez-Soto, I., Fernandez-Menendez, M. S., Fernandez-Martin, J. L., Macgregor, S. J., Brock, J. M., and Halls, D. 1991. Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int. 39:799-803.
17. Caramelo, C. A., Cannata, J. B., Rodeles, M. R., Fernandez-Martin, J. L., Mosquera, J. R., Monzu, B., Outerino, J., Blum, G., Andrea, C., Lopez Farre, A. J., Acuna, G., Casado, S., and Hernando, L. 1995. Mechanisms of aluminum-induced microcytosis: Lessons from accidental aluminum intoxication. Kidney Int. 47:164-168.
18. Chagnac, A., Ben-Basset, M., Weinstein, T., and Levi, J. 1987. Effect of long term aluminum administration on the renal structure of the rat. Nephron 47:66-69.
19. Chazan, J. A., Libbey, N. P., London, M. R., Pono, L., and Abuelo, J. G. 1991. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: A correlation between biochemical parameters and bone pathology findings. Clin. Nephrol. 35:78-85.
20. Cournot-Witmer, G., Zingraff, J., Plachott, J. J., Escaig, F., Lefevre, R., Boumati, P., Bourdeau, A., Garabedian, M., Galle, P., Bourdon, R., Drueke, T., and Balsan, S. 1981. Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization. Kidney Int. 20:375-385.
21. Deleers, M. 1985. Cationic atmosphere and cationic competition binding at negatively charged membranes: Pathological implications of aluminum. Res. Commun. Pathol. Pharmacol. 49:277-294.
22. Deleers, M., Servais, J. P., and Wulfert, E. 1986. Neurotoxic cations induce membrane rigidification and membrane fusion at micromolar concentrations. Biochim. Biophys. Acta 855:271-276.
23. Ebina, Y., Okada, S., Hamazaki, S., and Midorikawa, O. 1984. Liver, kidney and central nervous system toxicity of aluminum given intraperitoneally to rats: A multiple dose subchronic study using aluminum nitriloacetate. Toxicol. Appl. Pharmacol. 75:211-218.
24. Ecelbarger, C. A., and Greger, J. L. 1991. Dietary citrate and kidney function affect aluminum, zinc and iron utilization in rats. J. Nutr. 121:1755-1762.
25. Ecelbarger, C. A., MacNeil, G. G., and Greger, J. L. 1994a. Importance of kidney function and duration of exposure on aluminum accumulation in mature rats. Nutr. Res. 14:577-586.
26. Ecelbarger, C. A., MacNeil, G. G., and Greger, J. L. 1994b. Aluminum retention by aged rats fed aluminum and treated with desferrioxamine. Toxicology Lett. 73:249-257.
27. Ecelbarger, C. A., MacNeil, G. G., and Greger, J. L. 1994c. Tissue aluminum accumulation and toxic consequences in rats chronically fed aluminum with and without citrate. J. Agric. Food Chem. 42:2220-2224.
28. Exley, C., and Birchall, J. D. 1992. The cellular toxicity of aluminum. J. Theor. Biol. 159:83-98.
29. Exley, C., Burgess, E., Day, J. P., Jeffery, E. H., Melethil, S., and Yokel, R. A. 1996. Aluminum toxicokinetics. J. Toxicol. Environ. Health 48:569-584.
30. Faugere, M.-C., and Malluche, H. H. 1986. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int. 30:717-722.
31. Felsenfield, A. J., Rodriguez, M., Coleman, M., Ross, D., and Llach, F. 1989. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney Int. 35:1371-1378.
32. Fleming, J. T., and Joshi, J. G. 1991. Ferritin: The role of aluminum in ferritin function. Neurobiol. Aging 12:413-418.
33. Fournier, A., Moriniere, P., Cohen-Solal, M. E., Boudailliez, B., Achard, J. M., Marie, A., and Sebert, J. L. 1991. Adynamic bone disease in uremia: May it be idiopathic? Is it an actual disease? Nephron 58:1-12.
34. Fulton, B., and Jeffery, E. H. 1994a. Heme oxygenase induction: A possible factor in aluminum-associated anemia. Biol. Trace Element Res. 40:9-19.
35. Fulton, B., and Jeffery, E. H. 1994b. The temporal relationship between hepatic GSH loss, heme oxygenase induction, and cytochrome P450 loss following intraperitoneal aluminum administration to mice. Toxicol. Appl. Pharmacol. 127:291-297.
36. Goodman, W. G. 1986. Experimental aluminum-induced bone disease: Studies in vivo. Kidney Int. 29:S32-S36.
37. Goodman, W. G., Henry, D. A., Horst, R., Nudelman, R. K., Alfrey, A. C., and Coburn, J. W. 1984. Parenteral aluminum administration in the dog II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int. 25:370-375.
38. Greger, J. L., and Powers, C. F. 1992. Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats. Toxicology 76:119-132.
39. Greger, J. L., Chang, M. M., and MacNiel, G. G. 1994. Tissue turnover of aluminum and Ga-67: Effect of iron status. Proc. Soc. Exp. Biol. Med. 207:89-96.
40. Greger, J. L., Chang, M. M., and Radzanowski, G. M. 1995. Comparison of tissue retention of aluminum and gallium-67: Effect of iron status. Toxicology 100:1-9.
41. Halliwell, B., and Gutteridge, J. M. C. 1990. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186:1-85.
42. Harris, W. R., Berthon, G., Day, J. P., Exley, C., Flaten, T. P., Forbes, W. F., Kiss, T., Orvig, C., and Zatta, P. F. 1996. Speciation of aluminum in biological systems. J. Toxicol. Environ. Health 48:543-568.
43. Hercz, G., Pei, Y., Greenwood, C., Manuel, A., Saiphoo, C., Goodman, W. G., Segre, G. U., Fenton, S., and Sherrard, D. J. 1993. Aplastic osteodystrophy without aluminum: The role of suppressed parathyroid function. Kidney Int. 44:860-866.
44. Huang, Y. P., and Bittar, E. E. 1991. Protection by GTP from the effects of aluminum on the sodium efflux in barnacle muscle fibers. Biochim. Biophys. Acta 1062:255-263.
45. Huber, C. T., and Frieden, E. 1970. The inhibition of ferroxidase by trivalent and other metal ions. J. Biol. Chem. 245:3979-3984.
46. Jain, S. K., Abreo, K., Duett, J., and Sella, M. 1995. Lipofusion products, lipid peroxides and aluminum accumulation in red blood cells of hemodialyzed patients. Am. J. Nephrol. 15:306-311.
47. Jeffery, E. H. 1994. Biochemical mechanisms of aluminum toxicity. Handb. Exp. Pharmacol. 115:139-162.
48. Johnson, G. V. W., and Jope, R. S. 1987. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res. 403:1-6.
49. Karlik, S. J., and Eichhorn, G. L. 1989. Polynucleotide cross-linking by aluminum. J. Inorg. Biochem. 37:259-269.
50. Kasai, K., Hori, M. T., and Goodman, W. G. 1991. Transferrin enhances the antiproliferative effect of alumimium on osteoblast-like cells. Am. J. Physiol. 260:E537-E543.
51. Kleeman, C. R., Norris, K., and Coburn, J. W. 1987. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Mineral Electrolyte Metab. 13:305-310.
52. Koenig, M. L., and Jope, R. S. 1987. Aluminum inhibits the fast phase of voltage dependent calcium influx into synaptosomes. J. Neurochem. 49:316-320.
53. Lau, K.-H. W., Yoo, A., and Wang, S. P. 1991. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride. Mol. Cell. Biochem. 105:93-105.
54. Lau, K.-H. W., Utrapiromsuk, S., Yoo, A., Mohan, S., Strong, D. D., and Baylink, D. J. 1993. Mechanism of mitogenic action of aluminum ion on human bone cells: Potential involvement of the insulin-like growth factor regulatory system. Arch. Biochem. Biophys. 303:267-273.
55. 3. Kidney Int. 31:736-743.
56. Martin-Mateo, M. C., and De Torre, C. 1993. Erythrocyte catalase activity in chronic renal failure patients and donors in the presence of metal ions. Biol. Trace Element Res. 39:49-54.
57. McDonald, L. J., and Mamrack, M. D. 1988. Aluminum affects phosphoinositide hydrolysis by phosphoinositidase C. Biochem. Biophys. Res. Commun. 155:203-208.
58. McGregor, S. J., Naves, M. L., and Oria, R. 1991. Effect of aluminum on iron uptake and transferrin receptor expression by human erythroleukemia K562 cells. Biochem. J. 272:377-382.
59. Miller, J. L., Hubbard, C. M., Litman, B. J., and Macdonald, T. L. 1989. Inhibition of transducin activation and guanosine triphosphatase activity by aluminum ion. J. Biol. Chem. 264:243-250.
60. Monteagudo, F. S., Isaacson, L. C., Wilson, C., Hickman, R., and Folb, P. 1988. Aluminum excretion in the distal tubule of the pig kidney. Nephron 49:245-250.
61. Moressey, J., Rothstein, M., Mayor, G., and Slatopolsky, E. 1983. Suppression of parathyroid hormone secretion by aluminum. Kidney Int. 23:699-704.
62. Moshtaghie, A. A., and Bazrafshan, M. R. 1992. Comparative binding study of aluminum and chromium to human transferrin: Effect of iron. Biol. Trace Element Res. 32:39-45.
63. Nordal, K. P., Dahl, E., Halse, J., Aksnes, L., Thomassen, Y., and Flatmark, A. 1992. Aluminum metabolism and bone histology after kidney transplantation: A one-year follow-up study. J. Clin. Endrocrinol. Metab. 74:1140-1145.
64. Pei, Y., Hercz, G., Greenwood, C., Sherrard, D., Segre, G., Manual, A., Saiphoo, C., and Fenton, S. 1992. Noninvasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int. 41:1374-1382.
65. Quarles, L. D., Gitelman, H. J., and Drezner, M. K. 1986. Aluminum: Culprit or accessory in the genesis of renal osteodystrophy. Semin. Nephrol. 6:90-101.
66. Quarles, L. D., Wenstrup, R. J., Catillo, S. A., and Drezner, M. K. 1991. Aluminum-induced mitogenesis in MC3T3-E1 osteoblasts: Potential mechanism underlying neoosteogenesis. Endocrinology 128:3144-3151.
67. Quarles, L. D., Hartle, J. E. II, Middleton, P., Khang, J., Arthur, J. M., and Raymond, J. R. 1994. Aluminum-induced DNA synthesis in osteoblasts: Mediation by a G-protein coupled cation sensing mechanism. J. Cell. Biochem. 56:106-117.
68. Sahin, G., Varol, I., and Temizer, A. 1994. Determination of aluminum levels in the kidney, liver and brain of mice treated with aluminum hydroxide. Biol. Trace Element Res. 41:129-135.
69. Smith, A. J., Fuagere, M.-C., Abreo, K., Fanti, P., Julian, B., and Malluche, H. H. 1986. Aluminum-related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies in etiology and diagnosis. Am. J. Nephrol. 6:275-283.
70. Sternweis, P. C., and Gilman, A. G. 1982. Aluminum: A requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc. Natl. Acad. Sci. USA 79:4888-4891.
71. Thompson, G. N., Robertson, E. F., and Fitzgerald, S. 1985. Lead mobiliization during pregnancy. Med. J. Aust. 143:131.
72. Touam, M., Martinez, F., Lacour, B., Bourdon, R., Zingraff, J., Dicuilio, S., and Drueke, T. 1983. Aluminum-induced, reversible microcytic anemia in chronic renal failure: Clinical and experimental studies. Clin. Nephrol. 19:295-298.
73. Trapp, G. A. 1983. Plasma aluminum is bound to transferrin. Life Sci. 33:311-316.
74. Van der Voet, G. B., and DeWolff, F. A. 1987. The effect of di and trivalent iron on the intestinal absorption of aluminum in rats. Toxicol. Appl. Pharmacol. 90:190-197.
75. 2+ mobilization. FEBS Lett. 267:301-304.
76. Wills, M. R., Hewitt, C. D., Sturgill, B. C., Savory, J., and Herman, M. M. 1993. Long term oral or intravenous aluminum administration in rabbits. I. Renal and hepatic changes. Ann. Clin. Lab. Sci. 23:1-16.
77. Winearls, C. G., Oliver, D. O., Pippard, M. J., Ried, C., Downing, M. R., and Cotes, P. M. 1986. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2:1175-1178.